From Development to Delivery: Comprehensive Project Management for Functional VPs
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBlog
Gary Hutchinson is a controlled-environment logistics expert. His time-definite delivery networks deliver product around the world in a regulatory compliant and cost-effective way. He accomplishes this complex process by understanding environment and infrastructure, designing controls, and creating monitoring systems. Prior to launching Modality Solutions, Gary concentrated on life sciences. His focus has been on biologics, tissue heart valves, cardiac monitoring equipment, and perfusion systems.
Work Experience
Amgen / Thousand Oaks, CA
Edwards Lifesciences / Irvine, CA
Pioneer Electronics USA / Long Beach, CA
Education
Bachelor of Science, Economics / The Ohio State University
Master of Business Administration / The Ohio State University
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBlog
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBlog
10 Common Misconceptions of Cold Chain Validation, as Explained by AI, commentary by Gary...
read DetailsBlog
The biopharmaceutical industry is at a pivotal moment, particularly those involved in developing drugs...
read DetailsBlog
The Cold Chain Executive: The reality of being a C-Suite or senior executive Biopharmaceutical...
read DetailsBlog
The Cold Chain Executive: The reality of being a C-Suite or senior executive Biopharmaceutical...
read DetailsBlog
The Cold Chain Executive: The reality of being a C-Suite or senior executive Biopharmaceutical...
read DetailsBlog
The Cold Chain Executive: The reality of being a C-Suite or senior executive Biopharmaceutical...
read DetailsBlog
The Cold Chain Executive: The reality of being a C-Suite or senior executive Biopharmaceutical...
read DetailsBlog
How FDA processes have adapted from questionable EUA approvals to more stringent follow-up processes...
read DetailsBlog
In our previous post, we looked at some of the ways the biopharmaceutical industry...
read DetailsBlog
Recently, we worked on a project for an advanced CAR T-cell therapy developed by...
read DetailsBlog
September 9, 2021: Modality Solutions announced that Sumika Stansbury has joined the company as...
read DetailsPress & News